Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Development of a Novel Composite Process Measure for Venous Thromboembolism Prophylaxis.
Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of a Novel Composite Process Measure for Venous Thromboembolism Prophylaxis.
Development of a Novel Composite Process Measure for Venous Thromboembolism Prophylaxis. Med Care. 2016 Feb; 54(2):210-7.
View in:
PubMed
subject areas
Academic Medical Centers
Aged
Documentation
Female
Fibrinolytic Agents
Guideline Adherence
Humans
Inpatients
Intermittent Pneumatic Compression Devices
Length of Stay
Male
Middle Aged
Postoperative Complications
Practice Guidelines as Topic
Venous Thromboembolism
Walking
authors with profiles
Joseph Caprini